Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Optimi Health Corp (OP: OPTHF ) 0.2329 +0.0201 (+9.45%) Streaming Delayed Price Updated: 2:03 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 19,545 Open 0.2400 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.2128 Today's Range 0.2303 - 0.2600 52wk Range 0.1100 - 0.4300 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia June 05, 2024 Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia Via Benzinga Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga Performance YTD -0.04% -0.04% 1 Month -2.14% -2.14% 3 Month -27.54% -27.54% 6 Month +4.91% +4.91% 1 Year +52.72% +52.72% More News Read More Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Via Benzinga Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute April 09, 2024 Via Benzinga Two Top Biotechs Forge MDMA Supply Deals For Clinical Research March 26, 2024 Via Benzinga Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Via Benzinga Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More March 01, 2024 Via Benzinga Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Via Benzinga Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More January 08, 2024 Via Benzinga Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing September 08, 2023 Via Benzinga Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 Via Benzinga Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player August 01, 2023 Via Benzinga MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University June 20, 2023 Via Benzinga Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More May 23, 2023 Via Benzinga The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales May 17, 2023 Via Benzinga Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More May 15, 2023 Via Benzinga Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal May 11, 2023 Via Benzinga What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry April 03, 2023 Via Benzinga Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More March 07, 2023 Via Benzinga Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla March 06, 2023 Via Benzinga Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California March 02, 2023 Via Benzinga Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More February 13, 2023 Via Benzinga How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out February 09, 2023 Via Benzinga MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations February 06, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
